Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AniCura Køge Dyrehospital ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.4% 3.5% 2.3% 6.5% 3.2% 1.9% 10.6% 10.6%   Credit score (0-100)   65 53 63 36 55 70 23 23   Credit rating   BBB BBB BBB BBB BBB A BB BB   Credit limit (kDKK)   0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,499 12,124 6,334 11,996 15,653 16,316 0.0 0.0   EBITDA   2,415 1,852 550 -215 4,443 5,194 0.0 0.0   EBIT   2,118 1,485 333 -647 3,993 4,699 0.0 0.0   Pre-tax profit (PTP)   2,098.4 1,414.8 316.3 -645.6 4,150.6 5,052.9 0.0 0.0   Net earnings   1,632.3 1,099.3 254.2 -495.7 3,243.3 3,937.2 0.0 0.0   Pre-tax profit without non-rec. items   2,098 1,415 316 -646 4,151 5,053 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   1,483 1,433 1,896 1,837 1,434 1,527 0.0 0.0   Shareholders equity total   2,998 3,097 3,352 2,856 6,099 10,036 4,911 4,911   Interest-bearing liabilities   638 0.0 1,365 0.0 0.0 1,038 0.0 0.0   Balance sheet total (assets)   6,129 5,598 7,617 4,760 8,145 13,505 4,911 4,911   Net Debt   -1,843 -2,017 -2,746 -65.6 -60.0 952 -4,911 -4,911     See the entire balance sheet 1000.0 Volume  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,499 12,124 6,334 11,996 15,653 16,316 0.0 0.0   Gross profit growth   43.1% 5.4% -47.8% 89.4% 30.5% 4.2% -100.0% 0.0%   Employees   13 13 17 19 16 15 0 0   Employee growth %   44.4% 0.0% 30.8% 11.8% -15.8% -6.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,129 5,598 7,617 4,760 8,145 13,505 4,911 4,911   Balance sheet change%   45.8% -8.7% 36.1% -37.5% 71.1% 65.8% -63.6% 0.0%   Added value   2,414.8 1,852.0 550.5 -214.6 4,424.7 5,193.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   330 -418 246 -491 -853 -402 -1,527 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 5.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.4% 12.2% 5.3% -5.4% 25.5% 28.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   41.5% 25.4% 5.0% -10.2% 64.5% 46.7% 0.0% 0.0%   ROI %   68.0% 43.4% 8.5% -16.6% 92.4% 58.6% 0.0% 0.0%   ROE %   60.9% 36.1% 7.9% -16.0% 72.4% 48.8% 0.0% 0.0%   1000.0 Solidity  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   48.9% 55.3% 44.0% 60.0% 74.9% 74.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -76.3% -108.9% -498.9% 30.6% -1.3% 18.3% 0.0% 0.0%   Gearing %   21.3% 0.0% 40.7% 0.0% 0.0% 10.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.7% 22.9% 2.5% 2.3% 0.0% 0.1% 0.0% 0.0%   1000.0 Liquidity  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.2 1.3 1.2 1.1 2.9 3.2 0.0 0.0   Current Ratio   1.4 1.6 1.3 1.3 3.2 3.4 0.0 0.0   Cash and cash equivalent   2,481.1 2,017.0 4,111.2 65.6 60.0 86.3 0.0 0.0   1000.0 Capital use efficiency  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,237.9 1,381.6 1,106.0 655.1 4,339.4 8,132.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2020/5 2020 2021/5 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   186 142 32 -11 277 346 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   186 142 32 -11 278 346 0 0   EBIT / employee   163 114 20 -34 250 313 0 0   Net earnings / employee   126 85 15 -26 203 262 0 0